Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Latest impact factors for gastroenterology and hepatology journals

Interesting changes have been revealed from the latest gastroenterology and hepatology journal impact factors, for the year 2000.

News image

Gastroenterology is still the journal with the greatest impact factor, followed by Hepatology.

However, now in third place is Seminars in Liver Disease. This journal was 7th in 1999. Gut has therefore been displaced into 4th place.

Alimentary Pharmacology & Therapeutics is another improver - it has moved up to 6th place, from last year's position of 8th.

The impact factors are published by ISI. Their definition of an impact factor is "a measure of the frequency with which the 'average article' in a journal has been cited in a particular year or period."

The annual journal citation report impact factor is a ratio between citations and recent citable items published. Thus, the impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.

Journals with greatest impact:
1 Gastroenterology
2 Hepatology
3 Semin Liver Dis
4 Gut
5 J Hepatol
6 Aliment Pharmacol Ther
ISI

ISI explain that, "The impact factor is useful in clarifying the significance of absolute (or total) citation frequencies. It eliminates some of the bias of such counts, which favor large journals over small ones, or frequently issued journals over less frequently issued ones, and of older journals over newer ones. Particularly in the latter case such journals have a larger citable body of literature than smaller or younger journals.

"All things being equal, the larger the number of previously published articles, the more often a journal will be cited."

Here is the "Top Forty Four" of the impact factors for 2000:

Journal††††Impact factor
Gastroenterology††††12.246
Hepatology††††7.304
Semin Liver Dis††††6.012
Gut††††5.386
J Hepatol††††3.761
Aliment Pharmacol Ther††††3.489
Am J Physiol-Gastr L††††3.115
Am J Gastroenterol††††2.834
Gastrointest Endosc††††2.820
Helicobacter††††2.639
J Viral Hepat††††2.157
Liver Transplant††††2.130
Neurogastroenterol Motil††††2.081
Scand J Gastroenterol††††1.842
Endoscopy††††1.817
Hepatol Res††††1.808
Inflamm Bowel Dis††††1.791
Digestion††††1.780
Gastroenterol Clin North Am††††1.774
Liver††††1.739
Bailliere Clin Gastr††††1.733
Int J Colorectal Dis††††1.707
Dis Colon Rectum††††1.690
Can J Gastroenterol††††1.645
J Pediatr Gastroenterol Nutr††††1.580
Dig Dis Sci††††1.498
Ital J Gastroenterol††††1.289
Eur J Gastroenterol Hepatol††††1.142
J Clin Gastroenterol††††1.127
J Gastroenterol Hepatol††††1.116
World J Gastroenterol††††0.993
J Gastroenterol††††0.990
Gastroen Clin Biol††††0.927
Hepato-Gastroenterol††††0.905
Z Gatsroenterol††††0.887
Abdom Imaging††††0.886
Dig Surg††††0.810
Dig Dis††††0.744
Acta Gastro-Ent Belg††††0.605
Curr Opin Gastroen††††0.577
Rev Esp Enferm Dig††††0.384
J Diarrhoel Dis Res††††0.379
Chir Gastroenterol††††0.078
Best Pract Res Cl Ga††††0.067

ISI
03 September 2001

Go to top of page Email this page Email this page to a colleague

 28 February 2015

Advanced search
 27 February 2015 
Obesity and weight-loss therapy
 27 February 2015 
MRE performance in staging liver fibrosis
 27 February 2015 
Bleeding in diverticulosis
 26 February 2015 
Familial colorectal cancer risk and primary cancer
 26 February 2015 
Questionnaires for GERD
 26 February 2015 
Herbal products and the liver
 25 February 2015 
Exercise and NAFLD
 25 February 2015 
IBD in Korea
 25 February 2015 
Immunosuppressive therapy and T. whipplei
 24 February 2015 
Clinical trials in pediatric IBD
 24 February 2015 
Reducing health care costs in IBD
 24 February 2015 
GI bleeding after anticoagulation interruption
 23 February 2015 
Visceral abdominal obesity and IBS
 23 February 2015 
Crohn's outcomes with infliximab
 23 February 2015 
Intestinal microbiota and celiac disease
 20 February 2015 
H. pylori eradication
 20 February 2015 
Antiviral treatment and Hep C outcomes
 20 February 2015 
C. diff testing in IBD
 19 February 2015 
Intestinal microbiota in IBS
 19 February 2015 
Peptic ulcer bleeding mortality in liver disease
 19 February 2015 
Fecal microbial transplant in active Crohn's disease
 18 February 2015 
Genetic testing and GI cancers
 18 February 2015 
Placebo analgesia in functional abdominal pain
 18 February 2015 
Successful Hep C virus therapy
 17 February 2015 
Quality measures and colonoscopist selection
 17 February 2015 
Global incidence of esophageal cancer
 17 February 2015 
Anti-viral treatment and survival in Hep C
 16 February 2015 
Saliva for the diagnosis of GERD
 16 February 2015 
H pylori eradication therapy
 16 February 2015 
Medical marijuana for digestive disorders
 13 February 2015 
Beta-blockers in cirrhosis
 13 February 2015 
Liver disease and peptic ulcer bleeding
 13 February 2015 
Prevalence of microscopic colitis
 12 February 2015 
Liver disease in chronic Hep C
 12 February 2015 
Patient-reported outcomes in Hep C
 12 February 2015 
Patientsí colonoscopist selection
 11 February 2015 
NAFLD and CVD
 11 February 2015 
Guidelines for the diagnosis of hepatocellular carcinoma
 11 February 2015 
Hepatic decompensation in Hep C cirrhosis
 10 February 2015 
Percutaneous endoscopic gastrostomy
 10 February 2015 
Factors that influence hepatic steatosis
 10 February 2015 
Gene variants and Crohn's susceptibility
 09 February 2015 
Factors that influence gallstone surgery
 09 February 2015 
Factors associated with increased mortality in cirrhosis
 09 February 2015 
Use of immunomodulators in IBD
 06 February 2015 
Colorectal cancer risk in IBD
 06 February 2015 
H. pylori and peptic ulcer bleeding
 06 February 2015 
IBS and somatization
 05 February 2015 
GERD, dyspepsia and IBS symptoms
 05 February 2015 
Quality of life in Crohn's after antitumor necrosis factor agents
 05 February 2015 
Thalidomide and refractory Crohn's
 04 February 2015 
Telemedicine in IBD
 04 February 2015 
Infliximab and muscle wasting in Crohn's
 04 February 2015 
Resistance mutations in chronic Hep B
 03 February 2015 
Testosterone in advanced liver disease
 03 February 2015 
Mortality in peptic ulcer bleeding
 03 February 2015 
Colonoscopic remission of ulcerative colitis
 02 February 2015 
Colonoscopy and colon cancer risk in IBD
 02 February 2015 
Sirolimus in Hep C virus infected liver graft recipients
 02 February 2015 
Treatment of C. diff in adults

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us